[NEU] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
30-Dec-2017
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 127.37%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 717 495 13,990 631 3,150 1,673 2,931 -20.89%
PBT -9,910 -11,311 3,073 3,288 -12,014 -14,146 -8,316 2.96%
Tax -717 -495 -446 -631 -1,844 749 -19 83.04%
NP -9,193 -10,816 3,073 3,288 -12,014 -13,397 -8,297 1.72%
Tax Rate - - 14.51% 19.19% - - - -
Total Cost 9,910 11,311 10,917 -2,657 15,164 15,070 11,228 -2.05%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -1,282.15 -2,185.05 21.97 521.08 -381.40 -800.78 -283.08 28.59%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.09 -0.11 0.03 0.04 -0.14 -0.16 -0.11 -3.28%
EPS Diluted -0.09 -0.11 0.03 0.04 -0.14 -0.16 -0.11 -3.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.